- Crypto Litigation and Enforcement: Q1 2025 – Key Takeaways… | Fenwick
Success requires balancing innovation with prudent risk management and maintaining adaptable compliance frameworks Register below to watch the webinar on demand For the latest cryptocurrency news and regulatory developments, visit our Fenwick Crypto Review
- Noah Solowiejczyk | Fenwick
Noah Solowiejczyk draws on more than a decade as a federal prosecutor at the U S Attorney’s Office for the Southern District of New York to provide clear, actionable guidance in high-stakes, high-scrutiny cases He often works proactively with fast-growth and public companies to design compliance and risk management strategies that anticipate issues before they escalate, including in
- Jonathan Lenzner | Fenwick
Jonathan Lenzner is a nationally recognized leader in high-stakes crisis management, white collar investigations, and national security law and policy Jon’s leadership roles at the highest levels of government and business have equipped him with unparalleled skills in helping boards, executives, and leadership teams go on the offensive in managing risk and resolving sophisticated, multi
- Lexi Smith | Fenwick
Prior to joining Fenwick, Lexi was an associate in the capital markets group of a leading global law firm While attending law school, Lexi was a member of the UC Davis Law Review and UC Davis Business Law Journal and received the Witkin Award in securities regulation, international law and legal writing
- Delaware Revamps Its General Corporation Law — Will It Be… | Fenwick
Delaware has adopted significant, much anticipated amendments to §§ 144 and 220 of the Delaware General Corporation Law, which are aimed at providing greater clarity and predictability to corporate fiduciaries in light of certain recent controversial decisions from the Delaware Court of Chancery Those decisions have resulted in a number of high-profile companies reincorporating (or
- Eric A. Owens, Ph. D. | Fenwick
Eric counsels life sciences clients navigating the complex world of patent law across the chemical, biotech, and pharmaceutical sectors From positioning intellectual property portfolios for early-stage investments to leading IP diligence on buy- and sell-side asset acquisitions, Eric blends hands-on experience with advanced technologies and strategic insight As a trusted business adviser
- Jim Hauser | Fenwick
Jim advises technology and life sciences companies, investors, and executives on a broad range of executive compensation and employee benefits matters He has extensive experience supporting clients at all stages of growth—from early-stage startups to mature public companies—with a particular focus on the unique needs of emerging companies navigating rapid scale, IPO readiness, and complex
- Matthew Pavao, Ph. D. | Fenwick
Matt is a trusted adviser to biotechnology, pharmaceutical and medical device companies, guiding them through complex IP matters and market exclusivity strategies to drive business success With more than two decades of experience, he counsels public and private companies, including early- and mid-stage companies, on developing and leveraging their IP portfolios for financings, licensing and
|